Here are relevant reports on : diagnostic-disinfectant-market

• Veterinary Services Market by Service Type (Diagnostic Tests & Imaging, Surgery, Physical Health Monitoring, Vaccination), Animal Type (Food-producing, Companion), Delivery Channel (Hospitals & Clinics, Commercial facilities), and Region - Global Forecast to 2027

  The global veterinary services market size is projected to reach USD 139.2 billion by 2027 from USD 100 billion in 2022, at a CAGR of xx% during the forecast period. Market is driven by factors such as growing awareness for pet health, Increasing prevalence of various diseases in animals or zoonotic diseases, and rising demand for effective medical care. On the other hand, high cost of veterinary services and shortage of skilled personnel is expected to limit market growth to a certain extent in the coming years.

  • Published: December 2026
  • Price: $ 4950
  • TOC Available:

• European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025

  European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.

  • Published: May 2020
  • Price: $ 4950
  • TOC Available:

• Medical Image Management Market by Product (PACS (Departmental, Radiology, Mammography, Cardiology, Enterprise), VNA (On-premise, Hybrid, Cloud), AICA, Universal Viewer), End User (Hospitals, Diagnostic Imaging Centers, ASC, CRO) - Global Forecast to 2023

  The medical image management market is projected to reach USD 4.40 billion in 2023, growing at a CAGR of 7.7% . Prominent players in this market include McKesson Corporation (US), GE Healthcare (US), Fujifilm Holdings Corporation (Japan), Merge Healthcare Inc. (US), Agfa-Gevaert Group (Belgium), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Carestream Health, Inc. (US), BridgeHead Software (UK), Novarad Corporation (US), Mach7 Technologies Ltd. (US), and INFINITT Healthcare Co., Ltd.(South Korea).

  • Published: August 2018
  • Price: $ 4950
  • TOC Available:

• Single Cell Sequencing Market by Product (Reagents & Kits, Platforms, Software), Workflow (Presequencing), Service (Sample Preparation, Bioinformatics), Sequencing (scRNA, scDNA), Application (Research, Diagnostic), End User - Global Forecast to 2030

  The global Single Cell Sequencing market, valued at US$1.89 billion in 2024, stood at US$1.95 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$3.46 billion by the end of the period. This growth is driven by advancements in single-cell workflow, including more efficient cell isolation methods, improved library preparation kits, and high-throughput, cost-effective sequencing platforms.

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• Meat Speciation Testing Market by Species (Bos Taurus, Sus Scrofa, Gallus Gallus, Equus Caballus, Ovis Aries), Technology (PCR, ELISA, Molecular Diagnostic), Form (Raw, Cooked, Processed), and Region - Global Forecast to 2022

  The meat speciation testing market is projected to grow at a CAGR of 8.20% from 2016 to 2022, to reach a projected value of USD 2,220.6 Million by 2022. The market is driven by increase in number of adulteration and food fraud cases, religious beliefs, and compliance with labeling laws, and stringent regulations and consumer demand for certified products.

  • Published: January 2017
  • Price: $ 4950
  • TOC Available:

• CT/NG Testing Market by Product (Assays, Kits & Analyzers), Test Type (Laboratory, Point-of-care Testing), Technology (INAAT, PCR, Immunodiagnostics), End User (Diagnostic Labs, Hospitals & Clinics) & Region - Global Forecast to 2028

  The global CT/NG testing market, valued at US$1.6 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.7 billion by the end of the period. Market growth is largely driven by the increasing prevalence of CT/NG infections and the growing investments and funding for R&D in CT/NG diagnosis.

  • Published: July 2023
  • Price: $ 4950
  • TOC Available:

• Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Global Forecast to 2028

  The global theranostics market, valued at US$1.9 billion in 2022, stood at US$2.1 billion in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.3 billion by the end of the period. Increasing establishment of hospitals, rising focus on targeted therapies, and introduction of novel theranostic approaches are expected to drive the market during the forecast period.

  • Published: January 2024
  • Price: $ 4950
  • TOC Available:

• Metabolism Assays Market Size, Share & Trends by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028

  The global metabolism assays market, valued at US$1.3B in 2022, is forecasted to grow at a 7.8% CAGR, reaching US$1.4B by 2023 and US$2.1B by 2028. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

  • Published: September 2023
  • Price: $ 4950
  • TOC Available:

• Hepatitis Testing Market / Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026

  The global hepatitis testing market growth is primed to transition from $2.8 billion in 2021 to $3.6 billion by 2026, showcasing a strong CAGR of 4.7%. The growth of the global market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis.

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• US Veterinary Ophthalmology Equipment Market by Product (Diagnostic [Ophthalmoscopes, Tonometers], Surgical Equipment, Disposables, and Implants, Animal Type, End User (Veterinary Hospitals, Clinics) - Forecast to 2031

  The US veterinary ophthalmology equipment market, valued at USD 0.24 billion in 2025, stood at USD 0.26 billion in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2031, culminating in a forecasted valuation of USD 0.38 billion by the end of the period. The market is growing at a rapid pace, driven by the increasing pet ownership, awareness of pet disease, rising expenses of pet healthcare, a growing number of veterinary ophthalmologists, rising incidences of ocular disorders in veterinary cases, and the increasing use of advanced technologies in ophthalmology.

  • Published: November 2026
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50